Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
4.98M
-
Shares change
-
-367K
-
Total reported value, excl. options
-
$30.5M
-
Value change
-
-$2.11M
-
Number of buys
-
3
-
Number of sells
-
-16
-
Price
-
$6.03
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2018
29 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2018.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.98M shares
of 15M outstanding shares and own 33.3% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1.31M shares), ARIEL INVESTMENTS, LLC (1.18M shares), DIMENSIONAL FUND ADVISORS LP (880K shares), RENAISSANCE TECHNOLOGIES LLC (381K shares), Vanguard Group Inc (314K shares), BlackRock Inc. (307K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (200K shares), ACADIAN ASSET MANAGEMENT LLC (97.7K shares), BARD ASSOCIATES INC (78.1K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (53.8K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.